Despite significant neurobiological and pathological overlaps, Alzheimer's (AD) and Parkinson's (PD)-the primary threats to healthy aging-are still managed as distinct clinical entities. Standard machine learning exacerbates this fragmentation by pri...
Traditional clonogenic assays remain central to evaluating the self-renewal capacity of tumor cells. However, the assay relies on subjective endpoint measurements, is restricted to two-dimensional monolayer growth, and lacks the single cell resolutio...
Inferring the selective effects of copy-number alterations (CNAs) from clonal tumor data is essential for understanding tumor evolution. In practice, intra-tumor evolutionary parameters are typically estimated by fitting population genetic models to ...
Characterising equilibrium conformational ensembles with deep generative models requires assessing not only whether a model reproduces the target distribution, but also the mechanism of how it arrives here. Here we examine two distinct routes to gene...
The classification of pediatric brain tumors is investigated using deep learning on hematoxylin and eosin (H&E) and antigen Ki-67 (Ki-67) whole slide images (WSIs) from the Children's Brain Tumor Network (CBTN) dataset. A total of 1,662 unregistered ...
Current single-cell foundation models rely on language-model architectures that ignore transcriptomic data distributions, often underperforming specialized methods. We introduce xVERSE, a transcriptomics-native foundation model coupling batch-invaria...
A virtual cell is a world model of a cell: a computational system that predicts, simulates and programs cellular processes across modalities and scales. An important path toward this goal is to model how genetic and chemical perturbations give rise t...
Drug-resistant tuberculosis (TB), characterized by prolonged treatment regimens and suboptimal treatment outcomes, remains a major obstacle to global TB elimination. Advances in sequencing technologies have enabled the development of machine-learning...
Peripheral Blood transcriptome analysis evaluated the bulk transcript abundance (TA) covering all leukocyte cell populations. However, there are 2 main problems in using bulk expression as biomarkers: (1) A long list of differential expression genes ...
ABSTRACT Background: RNA editing is a post-transcriptional modification that alters the sequence of an RNA transcript. Two types of RNA editing were found in mammals, involving the enzymatic deamination of either adenosine to inosine (A-to-I) or cyti...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.